The US tariffs on China are expected to dampen China's exports, investment and consumption, dragging down its gross domestic product growth by 0.3 to 0.4 percentage points, says a UBS economist. Wang Tao, head of Asia economic research at the investment bank, expects the tariffs to negatively impact China’s inflation by about 0.2 percentage points. China might, based on past experience and scenario analysis, hold off on immediate countermeasures while keeping the door open for negotiations and cooperation, he said. Wang added that the recent tariff hike came promptly and at a lower rate but there remains considerable uncertainty about the timing and scale of additional tariffs, as the Trump administration is reviewing its trade policy, with reports due by April 1, when further tariff measures may be considered.

Melody Chen

United Nations (UN): Definition, Purpose, Structure, and Members

United Nations (UN): Definition, Purpose, Structure, and Members

The Prisoner’s Dilemma in Business and the Economy

The Prisoner’s Dilemma in Business and the Economy

Mainland firms' Hong Kong IPOs spark 'cautious optimism'

Mainland firms' Hong Kong IPOs spark 'cautious optimism'

Debates rage in China over living costs in HK

Debates rage in China over living costs in HK

China stocks get boost from box office draws

China stocks get boost from box office draws

70pc of Hongkongers dread rising living costs

70pc of Hongkongers dread rising living costs

China weighs probe into Apple’s app store fees, practices

China weighs probe into Apple’s app store fees, practices

CSI Properties lines up new projects

CSI Properties lines up new projects

Shein, Temu retailers now face 30pc levy

Shein, Temu retailers now face 30pc levy

Midday rally sees HSI surge past 21,000, Shanghai and Shenzhen post trillion-yuan turnover

Midday rally sees HSI surge past 21,000, Shanghai and Shenzhen post trillion-yuan turnover

China to roll back clean power subsidies after boom

China to roll back clean power subsidies after boom

China's health regulator defends quality of local generic drugs

China's health regulator defends quality of local generic drugs